Mail & Guardian
Mail & Guardian
oxford astrazenecalatest news & developments

To vaccinate or not to vaccinate – A human rights question

The South African Human Rights Commission reiterates its call in encouraging everyone to have themselves vaccinated against Covid-19

Government must find alternatives to AstraZeneca vaccine, say unions

Unions representing healthcare workers advise members to get vaccinated despite AstraZeneca postponement

The barcoding gap: Can South Africa protect its Covid jabs from crime?

Full track and traceability of Covid-19 jabs won’t happen during South Africa’s vaccine roll-out, as the health department has not yet adopted the “overarching” system that would…

Vigilant eyes will monitor South Africa’s first batch of vaccines

The department of health is also negotiating with manufacturers other than AstraZeneca to secure more than one type of vaccine

Bread and vaccines

Pharmaceutical companies stand to make billions from the Covid-19 pandemic, but the vaccines they have developed are the fruits of the collective labour of all of humanity.

City of Tshwane station officer Arrie Visser and special infection unit’s Rocco Veer do final checks on their isolation chamber before starting a night shift at the Hatfield Emergency Station. The chamber is equipped with a negative pressure filtration system and is used to transport positive Covid-19 patients. (Phill Magakoe/AFP)

Relief is near in the scramble for vaccines

The health minister has announced a glimmer of hope with SA having secured 1.5-million doses of the Oxford AstraZeneca vaccine

Health Minister Zweli Mkhize. (Delwyn Verasamy/M&G)

Secured: 1.5mn doses of Oxford/AstraZeneca vaccine

Just days after Minister Zweli Mkhize came under fire for the government’s apparent slow take on securing the vaccine, he announced to Parliament that the first batch of dosages…

A health official tries to drop a polio vaccine into the mouth of a child at Kaiama town in Bayelsa State.

Covid vaccines: Hope balanced with caution

As Covid vaccines near the manufacturing stage, a look at two polio vaccines provides valuable historical insights